Contracted Activities

The University makes its innovative know-how, as well as the experience and expertise of its professors and researchers, available to companies and public entities (https://www.uniroma1.it/it/pagina/contratti-conto-terzi).
Third-party activities (attività conto terzi), provided for by Art. 66 of Presidential Decree 11.7.1980, n. 382, pursue the University's objective of strengthening its ties with the local area by offering quality services that enhance academic expertise, compatible with its scientific and educational functions and within the scope of its institutional and statutory purposes. An increasing number of public and private entities turn to the University to commission projects, research, and consultancy services across the manifold areas of expertise available within the institution.
The Department of Experimental Medicine has signed agreements for third-party activities with various economic stakeholders for specialised research activities.

The agreements active as of December 31, 2022 are:

N. protocolloSTUDYPERSON IN CHARGE
Prot. 237/2020Novo Nordisk Studio NN9535-4321Prof. CAVALLO
Prot. 300/2020Opis Srl Studio GLARGR09384- RESTORE-2Prof. BUZZETTI
Prot. 1163/2020Parexel International Studio NN9535-4549 – SUREProf. BUZZETTI
Prot. 1639/2020Icon Public Limited C. Studio CORT125134-452Prof. ISIDORI
Prot. 2320/2020Coresearch Srl Studio Annali AMDProf. BUZZETTI
Prot. 2367/2020Dompé Farmaceutici SpA Studio LDX0419Prof. BUZZETTI
Prot. 483/2021Medineos SURL Studio 6153 REX – NN9068-4740Prof. BUZZETTI
Prot. 620/2021Icon Clinical Research L. Studio CORT125134-456Prof. ISIDORI
Prot. 682/2021Dompé Farmaceutici spa Studio LDX0319Prof. BUZZETTI
Prot. 1329/2021Neurocrine Biosciences Studio NBI-74788-CAH3003Prof. ISIDORI
Prot. 1438/2021Scope International AG Studio HDR-0320-DRProf. MORANO
Prot. 1457/2021Novo Nordisk SpA Studio NN1436-4480Prof. BUZZETTI
Prot. 1677/2021Novo Nordisk SpA Studio NN1436-4625Prof. BUZZETTI
Prot. 1786/2021Azienda Ospedalieri Ospedali Riuniti Marche NordProf. ANGELONI
Prot. 2615/2022Ascendis Pharma Studio TCH-306Prof. ISIDORI
Prot. 4300/2022Novo Nordisk Spa Studio REDEFINE-1Prof. GNESSI
Prot. 4303/ 2022 Astrazeneca SpA Studio D5671C00006Prof. CAVALLO

 

Back to top